Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03420430
Title Expanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of Care
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Genelux Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.